ABVC
Price
$3.10
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
52.81M
MRSN
Price
$0.29
Change
+$0.01 (+3.57%)
Updated
Jul 3 closing price
Capitalization
36.08M
32 days until earnings call
Interact to see
Advertisement

ABVC vs MRSN

Header iconABVC vs MRSN Comparison
Open Charts ABVC vs MRSNBanner chart's image
ABVC BioPharma
Price$3.10
Change-$0.00 (-0.00%)
Volume$6.07K
Capitalization52.81M
Mersana Therapeutics
Price$0.29
Change+$0.01 (+3.57%)
Volume$1.86M
Capitalization36.08M
ABVC vs MRSN Comparison Chart in %
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. MRSN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and MRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ABVC: $3.10 vs. MRSN: $0.29)
Brand notoriety: ABVC and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 2% vs. MRSN: 65%
Market capitalization -- ABVC: $52.81M vs. MRSN: $36.08M
ABVC [@Biotechnology] is valued at $52.81M. MRSN’s [@Biotechnology] market capitalization is $36.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 4 TA indicator(s) are bullish while MRSN’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 4 bullish, 4 bearish.
  • MRSN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABVC and MRSN are a good buy in the short-term.

Price Growth

ABVC (@Biotechnology) experienced а +41.55% price change this week, while MRSN (@Biotechnology) price change was -10.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ABVC is expected to report earnings on Apr 15, 2025.

MRSN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVC($52.8M) has a higher market cap than MRSN($36.1M). ABVC YTD gains are higher at: 425.424 vs. MRSN (-79.755). ABVC has higher annual earnings (EBITDA): -2.31M vs. MRSN (-68.42M). MRSN has more cash in the bank: 102M vs. ABVC (217K). ABVC has less debt than MRSN: ABVC (2.17M) vs MRSN (24.6M). MRSN has higher revenues than ABVC: MRSN (34M) vs ABVC (508K).
ABVCMRSNABVC / MRSN
Capitalization52.8M36.1M146%
EBITDA-2.31M-68.42M3%
Gain YTD425.424-79.755-533%
P/E RatioN/AN/A-
Revenue508K34M1%
Total Cash217K102M0%
Total Debt2.17M24.6M9%
FUNDAMENTALS RATINGS
ABVC vs MRSN: Fundamental Ratings
ABVC
MRSN
OUTLOOK RATING
1..100
2511
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3493
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (67) in the null industry is in the same range as MRSN (88) in the Biotechnology industry. This means that ABVC’s stock grew similarly to MRSN’s over the last 12 months.

ABVC's Profit vs Risk Rating (100) in the null industry is in the same range as MRSN (100) in the Biotechnology industry. This means that ABVC’s stock grew similarly to MRSN’s over the last 12 months.

ABVC's SMR Rating (96) in the null industry is in the same range as MRSN (100) in the Biotechnology industry. This means that ABVC’s stock grew similarly to MRSN’s over the last 12 months.

ABVC's Price Growth Rating (34) in the null industry is somewhat better than the same rating for MRSN (93) in the Biotechnology industry. This means that ABVC’s stock grew somewhat faster than MRSN’s over the last 12 months.

ABVC's P/E Growth Rating (100) in the null industry is in the same range as MRSN (100) in the Biotechnology industry. This means that ABVC’s stock grew similarly to MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCMRSN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHOTF0.32N/A
N/A
American Hotel Income Properties REIT LP
DNTUF21.85N/A
N/A
Dentsu Group Inc.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
UEPEO72.50N/A
N/A
Union Electric Co.
VIORF0.10N/A
N/A
VIOR INC.

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
N/A
KNSA - ABVC
40%
Loosely correlated
+1.60%
MRSN - ABVC
33%
Loosely correlated
+3.50%
MLEC - ABVC
31%
Poorly correlated
+0.58%
FULC - ABVC
27%
Poorly correlated
-0.14%
MDXXF - ABVC
25%
Poorly correlated
+3.30%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+3.50%
IGMS - MRSN
55%
Loosely correlated
+3.03%
CRNX - MRSN
48%
Loosely correlated
+1.22%
DYN - MRSN
47%
Loosely correlated
-2.01%
DNLI - MRSN
42%
Loosely correlated
-1.41%
RGNX - MRSN
42%
Loosely correlated
+1.39%
More